SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-17-006522
Filing Date
2017-04-14
Accepted
2017-04-14 09:10:20
Documents
2
Effectiveness Date
2017-04-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A dmtx-defa14a_20170525.htm DEFA14A 26943
2 GRAPHIC g201704131324028213034.jpg GRAPHIC 124455
  Complete submission text file 0001564590-17-006522.txt   199533
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Filer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37601 | Film No.: 17762223
SIC: 2836 Biological Products, (No Diagnostic Substances)